Viewing Study NCT00169169


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-04-03 @ 6:46 PM
Study NCT ID: NCT00169169
Status: TERMINATED
Last Update Posted: 2005-09-15
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
Sponsor: Lymphoma Study Association
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CD20-Positive Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diffuse large B cell lymphoma View
None Rituximab View
None Autotransplant View